Sun, Feb 1, 2015, 9:49 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Facebook, Inc. (FB) Message Board

  • biojax biojax Dec 4, 2013 4:43 PM Flag



    In case you want a brief picture of ATHX:

    Potential catalysts
    ●End of enrollment for the ulcerative colitis trial
    ●Initiation of the GvHD phase II/III trial
    ●Initiation of the acute myocardial infarction phase II trial
    ●Realization of a partnership for the obesity drug
    ●Realization of a partnership for ischemic stroke
    ●Future grants or awards
    ●Potential milestone payments from RTI or Pfizer
    ●Legislation for Regenerative Medicine in Japan, may bring fast development path news.

    Huge catalysts:

    ★ UC trial results\data release ★ IS trial results\data release


    ✔ Existing investor asked them if they could buy more shares. This is an institutional size investor. They do homework!!!! Think about it $20 million!!! (how often do you see this?)

    Acute myocardial infarction phase II trial - may have two catalysts: Initiation as listed above and a partnering per the webcast today.

    Also "aggressively going after Japan" per webcast today 12/4/2013

    Read: U.S. Biotech Investor - on Seeking Alpha

    This topic is deleted.
75.91-2.09(-2.68%)Jan 30 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.